|
Thyroid Nodule
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Participants were further stratified into thyroid autoantibody positive group (at least one positive) and thyroid autoantibody negative group (both negative) according to the thyroglobulin antibody (TGAb) and thyroid peroxidase antibody (TPOAb) levels, and restricted cubic spline regression was also applied to determine the possible nonlinear relationship between urinary BPA and TNs.
|
30825751 |
2019 |
|
Thyroid Nodule
|
0.100 |
Biomarker
|
disease |
BEFREE |
We aimed to evaluate the effects of Tg on the function of Tregs in patients with thyroid nodules.
|
30822273 |
2019 |
|
Thyroid Nodule
|
0.100 |
Biomarker
|
disease |
BEFREE |
Thyroglobulin, age, pre-pregnancy body mass index, and iodine-excessive region were associated with TNs (odds ratio = 1.01, 1.06, 1.04, and 2.38, respectively).
|
30979661 |
2019 |
|
Thyroid Nodule
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
We successfully established and validated a simple and reliable preoperative prediction model for FTC using the preoperative thyroglobulin level and ultrasonographic features of the thyroid nodules.
|
31050007 |
2019 |
|
Thyroid Nodule
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Associations between preoperative TG levels and size of largest malignant nodule, thyroid gland size, stage of cancer, and presence of metastasis using Wilcoxon rank sum tests and Spearman correlations were performed.
|
29948933 |
2018 |
|
Thyroid Nodule
|
0.100 |
Biomarker
|
disease |
BEFREE |
Changes in serum thyroglobulin and antithyroglobulin shortly following high-intensity focused ablation of benign thyroid nodules in patients with positive antithyroglobulin status.
|
30303432 |
2018 |
|
Thyroid Nodule
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Thyroglobulin levels were higher in subjects with prevalent thyroid nodules (26.1 ng/mL vs 9.37 ng/mL; <i>P</i> < 0.001) and in those who had an initial normal examination but later developed thyroid nodules (11.2 ng/mL vs 8.87 ng/mL; <i>P</i> = 0.017).
|
29453230 |
2018 |
|
Thyroid Nodule
|
0.100 |
Biomarker
|
disease |
BEFREE |
We designed this study to determine whether the preoperative thyroglobulin (Tg) and change in serum Tg during thyroid-stimulating hormone (TSH) suppression can predict FTC in thyroid nodules with a cytological diagnosis of follicular lesion.
|
27936964 |
2017 |
|
Thyroid Nodule
|
0.100 |
Biomarker
|
disease |
BEFREE |
Serum growth differentiation factor 15, thyroid function, thyroid autoantibodies, thyroglobulin and other biochemical indicators were measured and compared between thyroid nodule positive and negative groups.
|
28489602 |
2017 |
|
Thyroid Nodule
|
0.100 |
Biomarker
|
disease |
BEFREE |
The thyroid hormone level in the thyroid nodules group was significantly higher than the non-nodules group (all <i>p</i> values < 0.05), except reversely in TSH (thyroid stimulating hormone) (<i>p</i> = 0.0532) and TGAb (thyroglobulin antibody) (<i>p</i> = 0.0004).
|
28678169 |
2017 |
|
Thyroid Nodule
|
0.100 |
Biomarker
|
disease |
BEFREE |
The percentage of serum thyroglobulin rise in the first-week did not predict the eventual success of high-intensity focussed ablation (HIFU) for benign thyroid nodules.
|
28793806 |
2017 |
|
Thyroid Nodule
|
0.100 |
Biomarker
|
disease |
BEFREE |
Thyroglobulin stability after storage at -20 °C up to 14 days was studied in washout performed with normal saline solution and further dilutions with normal saline solution from five metastatic thyroid nodes and six benign thyroid nodules.
|
28386723 |
2017 |
|
Thyroid Nodule
|
0.100 |
Biomarker
|
disease |
BEFREE |
In FNAC studies, the association between HT and PTC is based on the comparison of anti-thyroid autoantibodies (ATA) (anti-thyroperoxidase [TPOAb] and anti-thyroglobulin [TgAb]), thyroid function (TSH), and cytology with histology of thyroid nodules and lymphocytic thyroid infiltration (LTI) of operated thyroid glands.
|
28868258 |
2017 |
|
Thyroid Nodule
|
0.100 |
Biomarker
|
disease |
BEFREE |
Thyrotropin receptor messenger RNA provides complementary evaluation to thyroglobulin and fine-needle aspiration for pediatric thyroid nodule management.
|
22244412 |
2012 |